In early March, the NET Research Foundation was in attendance for the first time at the European Neuroendocrine Tumor Society (ENETS) Conference, which took place this year in Barcelona. With nearly 2,000 people in attendance, covering a multitude of countries and specialties, the conference enabled us to connect with the world leaders in neuroendocrine cancer treatment and research. Our booth, which displayed NETRF materials, including information on our research grants and the recent announcement of the $15 million gift from the Margie and Robert E. Petersen Foundation, attracted substantial interest from conference participants. Ron Hollander, NETRF Executive Director and Dr. George Fisher, NETRF Board of Scientific Advisors Co-Chair, held meetings with a number of prominent European leaders in NET research to explore ways to collaborate and make significant progress on the path to discovering cures for NETs.
Said Martyn Caplin, Chairman of ENETS: “There are pressing needs for research that can help us understand the basic biology of NETs, and help us determine what treatments, sequencing, and combinations work best, and how new options such as immunotherapy can be employed to improve the chances for survival, quality of life and cure. Especially given the lack of public funding for NET research, there is a critical need for organizations such as NETRF and INCA to advocate for and secure support that can help us address these critical needs.”